Latest period
$2.25B
YoY change
-8.0%
5Y CAGR
+32.9%
Peak year (2024)
$2.56B
Latest annual
$2.35B
Total Assets history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: $2.35B
Total Assets growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: -8.0%
Total Assets history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | $2.35B | -8.0% | −$203.79M | ||
| 2024 | $2.56B | +24.1% | +$496.60M | ||
| 2023 | $2.06B | +153.9% | +$1.25B | ||
| 2022 | $811.93M | +10.0% | +$73.94M | ||
| 2021 | $737.99M | +30.1% | +$170.59M | ||
| 2020 | $567.40M | +157.3% | +$346.87M | ||
| 2019 | $220.53M | +29.3% | +$49.94M | ||
| 2018 | $170.59M | +1031.4% | +$155.51M | ||
| 2017 | $15.08M | — | — |
- 2025$2.35B-8.0%
- 2024$2.56B+24.1%
- 2023$2.06B+153.9%
- 2022$811.93M+10.0%
- 2021$737.99M+30.1%
- 2020$567.40M+157.3%
- 2019$220.53M+29.3%
- 2018$170.59M+1031.4%
- 2017$15.08M—
Total Assets values are taken from Revolution Medicines's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's latest reported total assets is $2.25B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Revolution Medicines (RVMD) total assets is $2.35B – declined 8.0% year-over-year.
Revolution Medicines total assets compound annual growth for the 2020–2025 (5 years) window is +32.9%, with mixed annual results across the window.
Between 2024 and 2025, Revolution Medicines total assets declined 8.0%, falling from $2.56B to $2.35B.
The highest annual total assets of $2.56B was reported in 2024. The lowest in the available history was $15.08M in 2017.
Revolution Medicines Total Assets by Year
Revolution Medicines Total Assets 2025: $2.35B
2025's total assets for Revolution Medicines came in at $2.35B, declined 8.0% below 2024.
Revolution Medicines Total Assets 2024: $2.56B
Revolution Medicines posted total assets of $2.56B in 2024, grew 24.1% from 2023. This figure represents the highest annual value in the available history.
Revolution Medicines Total Assets 2023: $2.06B
In 2023, Revolution Medicines reported total assets of $2.06B, surged 153.9% from 2022.
Revolution Medicines Total Assets 2022: $811.93M
Revolution Medicines total assets in 2022 was $811.93M, grew 10.0% from 2021.
Revolution Medicines Total Assets 2021: $737.99M
Revolution Medicines total assets in 2021 was $737.99M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Total Assets
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation